Natural Product: NPC515719

Natural Product IDNPC515719
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
3-oxo-3-[[(2~{R},3~{R},4~{S},5~{S},6~{S})-3,4,5-trihydroxy-6-[2-(4-hydroxyphenyl)-7-methoxy-4-oxo-chromen-5-yl]oxy-tetrahydropyran-2-yl]methoxy]propanoic acid
IUPAC Name 3-oxo-3-[[(2~{R},3~{R},4~{S},5~{S},6~{S})-3,4,5-trihydroxy-6-[2-(4-hydroxyphenyl)-7-methoxy-4-oxo-chromen-5-yl]oxy-tetrahydropyran-2-yl]methoxy]propanoic acid
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID n.a.
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey WZEYEVDCZWOQJH-FYOOOJEWSA-N
Standard InCHI InChI=1S/C25H24O13/c1-34-13-6-16-21(14(27)8-15(36-16)11-2-4-12(26)5-3-11)17(7-13)37-25-24(33)23(32)22(31)18(38-25)10-35-20(30)9-19(28)29/h2-8,18,22-26,31-33H,9-10H2,1H3,(H,28,29)/t18-,22+,23+,24+,25-/m1/s1
SMILES COC1=CC(O[C@@H]2O[C@H](COC(=O)CC(=O)O)[C@H](O)[C@H](O)[C@@H]2O)=C2C(=O)C=C(C3=CC=C(O)C=C3)OC2=C1

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   532.12 Volume:   494.639
?
Van der Waals volume.
Dense:   1.076 LogP:   1.038
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.475
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.113
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   9.0 Rigid Bonds:   26.0
TPSA:   202.42
?
Topological Polar Surface Area.
H-Bond Acceptor:   13.0
H-Bond Donor:   5.0 Rings:   4.0
Heavy Atoms:   13.0

MedChem Properties

QED Drug-Likeness Score:   0.197 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.997 Fsp3:   0.32
MCE-18:   89.182
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.489 Fluc inhibitor:   0.307
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.964
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.859
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.026 Promiscuous compounds:   0.333

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.075 MDCK Permeability:   -5.292
Pgp-inhibitor:   0.0 Pgp-substrate:   0.101
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.162
20% Bioavailability (F20%):   0.715 30% Bioavailability (F30%):   0.786
50% Bioavailability (F50%):   0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.791
Plasma Protein Binding (PPB):   83.707% Volume Distribution (VD):   -0.068
Fu: 18.103%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.963
OATP1B3 inhibitor:   0.997 BCRP inhibitor:   0.006
BSEP inhibitor:   0.001

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.017 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.345
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.008
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.996
HLM stability:   0.045
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  0.975 Half-life (T1/2):  2.068

ADMET: Toxicity

hERG Blockers:  0.007 hERG Blockers (10um):  0.019
Human Hepatotoxicity (H-HT):  0.593 Drug-induced Liver Injury (DILI):  0.995
AMES Toxicity:  0.964 Rat Oral Acute Toxicity:  0.239
Maximum Recommended Daily Dose:  0.29 Skin Sensitization:  1.0
Carcinogencity:  0.674 Eye Corrosion:  0.0
Eye Irritation:  0.754 Respiratory Toxicity:  0.222
Drug-induced Neurotoxicity:  0.09 Ototoxicity:  0.58
Hematotoxicity:  0.832 Drug-induced Nephrotoxicity:  0.911
Genotoxicity:  0.998 RPMI-8226 Immunitoxicity:  0.12
A549 Cytotoxicity:  0.443 Hek293 Cytotoxicity:  0.552
BCF:   0.28
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   2.892
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.271
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.544
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO21528 Equisetum arvense Species Equisetaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO21528 Equisetum arvense Species Equisetaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO21528 Equisetum arvense Species Equisetaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO21528 Equisetum arvense Species Equisetaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO21528 Equisetum arvense Species Equisetaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC515719 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7753 Intermediate Similarity NPC64051
0.7528 Intermediate Similarity NPC129827
0.7174 Intermediate Similarity NPC46202
0.7143 Intermediate Similarity NPC473512
0.7021 Intermediate Similarity NPC229409
0.6739 Remote Similarity NPC295613
0.6591 Remote Similarity NPC610763
0.6383 Remote Similarity NPC473657
0.6344 Remote Similarity NPC172807
0.6316 Remote Similarity NPC15358
0.6289 Remote Similarity NPC284277
0.6117 Remote Similarity NPC121703
0.596 Remote Similarity NPC475497
0.58 Remote Similarity NPC475366
0.5784 Remote Similarity NPC270675
0.5784 Remote Similarity NPC195685
0.5701 Remote Similarity NPC472993
0.567 Remote Similarity NPC211594
0.5657 Remote Similarity NPC44931
0.5652 Remote Similarity NPC110349
0.5638 Remote Similarity NPC182045
0.5631 Remote Similarity NPC479766
0.5619 Remote Similarity NPC472994
0.5612 Remote Similarity NPC254540
0.5577 Remote Similarity NPC479765
0.5521 Remote Similarity NPC284960
0.5484 Remote Similarity NPC83283
0.5474 Remote Similarity NPC27942
0.5377 Remote Similarity NPC101636
0.5377 Remote Similarity NPC298171
0.5315 Remote Similarity NPC277532
0.5294 Remote Similarity NPC22062
0.5294 Remote Similarity NPC473634
0.5294 Remote Similarity NPC138811
0.5213 Remote Similarity NPC331652
0.5189 Remote Similarity NPC488089
0.5158 Remote Similarity NPC39360
0.5158 Remote Similarity NPC29763
0.5158 Remote Similarity NPC210003
0.514 Remote Similarity NPC477629
0.5104 Remote Similarity NPC93337
0.5102 Remote Similarity NPC282169
0.5096 Remote Similarity NPC204693
0.5094 Remote Similarity NPC473623
0.5052 Remote Similarity NPC105025
0.505 Remote Similarity NPC477848
0.5046 Remote Similarity NPC470450

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC515719 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.566 Remote Similarity NPD7472 Pre-clinical

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data